Novel method to detect corneal lymphatic vessels in vivo by intrastromal injection of fluorescein
VNH Le, Y Hou, J Horstmann, F Bock, C Cursiefen - Cornea, 2018 - journals.lww.com
VNH Le, Y Hou, J Horstmann, F Bock, C Cursiefen
Cornea, 2018•journals.lww.comPurpose: Corneal lymphatic vessels are clinically invisible because of their thin walls and
clear lymph fluid. There is no easy and established method for in vivo imaging of corneal
lymphatic vessels so far. In this study, we present a novel approach to visualize corneal
lymphatic vessels in vivo by injecting intrastromal fluorescein sodium. Methods: Six-to eight-
week-old female BALB/c mice were used in the mouse model of suture-induced corneal
neovascularization. Two weeks after the suture placement, fluorescein sodium was injected …
clear lymph fluid. There is no easy and established method for in vivo imaging of corneal
lymphatic vessels so far. In this study, we present a novel approach to visualize corneal
lymphatic vessels in vivo by injecting intrastromal fluorescein sodium. Methods: Six-to eight-
week-old female BALB/c mice were used in the mouse model of suture-induced corneal
neovascularization. Two weeks after the suture placement, fluorescein sodium was injected …
Abstract
Purpose:
Corneal lymphatic vessels are clinically invisible because of their thin walls and clear lymph fluid. There is no easy and established method for in vivo imaging of corneal lymphatic vessels so far. In this study, we present a novel approach to visualize corneal lymphatic vessels in vivo by injecting intrastromal fluorescein sodium.
Methods:
Six-to eight-week-old female BALB/c mice were used in the mouse model of suture-induced corneal neovascularization. Two weeks after the suture placement, fluorescein sodium was injected intrastromally. The fluorescein, taken up by the presumed lymphatic vessels, was then tracked using a clinically used Spectralis HRA+ OCT device. Immunohistochemistry staining with specific lymphatic marker LYVE-1 and pan-endothelial marker CD31 was used to confirm the indirect lymphangiography findings.
Results:
By injecting fluorescein intrastromally, both corneal blood and lymphatic vessels were detected. While the lymphatic vessels were visible as bright vessel-like structures using HRA, the blood vessels appeared as dark networks. Fluorescein-labeled lymphatic vessels were colocalized with LYVE-1 in immunohistochemically stained sections of the same specimen.
Conclusions:
Corneal lymphatic vessels can be easily imaged in vivo in the murine model using intrastromal fluorescein injection.
Lippincott Williams & Wilkins